{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-036296","form_type":"8-K","ticker":"TNYA","cik":"0001858848","company_name":"Tenaya Therapeutics, Inc.","filed_at":"2025-03-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:05.348368+00:00","generated_at":"2026-05-25T02:09:05.368428+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Tenaya Therapeutics reports Q4 2024 net loss of $23.8M; cash runway extended to mid-2026 after $48.9M offering","bullets":["Net loss of $23.8M ($0.28 per share) for Q4 2024; full-year net loss $111.1M ($1.31 per share).","Cash and investments $61.4M at Dec 31, 2024; after $48.9M March 2025 offering, runway into mid-2026.","Dosing initiated in Cohort 2 (6E13 vg/kg) of MyPEAK-1 Phase 1b/2 trial for TN-201; Cohort 1 data accepted as ACC late-breaker.","First patient dosed in RIDGE-1 Phase 1b trial for TN-401; initial data expected in 2H25; CIRM awarded $8M grant.","Hiro Higa promoted to SVP, Finance and interim principal accounting officer."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-036296","json":"https://secwatch.observer/filing/0000950170-25-036296.json","markdown":"https://secwatch.observer/filing/0000950170-25-036296.md","text":"https://secwatch.observer/filing/0000950170-25-036296.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1858848/000095017025036296/0000950170-25-036296-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1858848/000095017025036296/tnya-20250310.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-25T02:09:05.368428+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}